Skip to main content

Table 3 Comparison of HCAP risk factors between MRSA and non-MRSA pneumonia a

From: Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia

Risk factors MRSA Non-MRSA P-value
Hospitalization for ≥ 2 d in the preceding 90d 50 (64.1) 313 (36.2) < 0.001
Residence in a nursing home or extended care facility 16 (20.5) 74 (8.6) 0.001
Intravenous antibiotic treatment within 30 days 22 (28.2) 80 (9.2) <0.001
Chemotherapy within 30 days of pneumonia 6 (7.7) 115 (13.3) 0.156
Wound care within 30 days of pneumonia 1 (1.3) 4 (0.5) 0.351
Hemodialysis clinic 2 (2.6) 30 (3.5) 1
  1. aData are presented as numbers (percentages) unless otherwise indicated.
  2. Abbreviations: HCAP healthcare-associated pneumonia, MRSA methicillin-resistant Staphylococcus aureus.